Second Affiliated Hospital of Soochow University

• NCT07836140

  Phase 2, Completed, 60 people, 23 Sept 2026

• Application of Artificial Intelligence in Transcranial Ultrasound

  Status unknown, 800 people, 16 Sept 2026

• Individualized Non-Invasive Neuromodulation for Central Neurodegenerative Diseases Guided by Multimodal Neural Signal Decoding

  Status unknown, 177 people, 22 Jul 2026

• NCT07323381

  Collaborator, Phase 4, Not yet recruiting, 116 people, 7 Jan 2026

• NCT07153744

  Collaborator, Phase 4, Not yet recruiting, 9,588 people, 4 Sept 2025

• NCT07095790

  Phase 4, Recruiting, 580 people, 31 Jul 2025

• NCT07002099

  Phase 2, Recruiting, 26 people, 3 Jun 2025

• A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence

  Collaborator, Phase 4, Recruiting, 86 people, 21 Jun 2024

• NCT06236230

  Phase 4, Status unknown, 60 people, 1 Feb 2024

• NCT04087967

  Collaborator, Phase 3, Status unknown, 162 people, 12 Sept 2019

• NCT04083911

  Collaborator, Phase 3, Status unknown, 50 people, 10 Sept 2019

• NCT03503136

  Collaborator, Phase 3, Status unknown, 632 people, 19 Apr 2018

• NCT03106935

  Early phase 1, Status unknown, 300 people, 11 Apr 2017

• NCT02484027

  Phase 4, Status unknown, 456 people, 29 Jun 2015

• NCT02129985

  Collaborator, Phase 4, Status unknown, 100 people, 2 May 2014

• NCT02027220

  Phase 2, Status unknown, 60 people, 6 Jan 2014

Sources: trialsearch.who.int, clinicaltrials.gov

• Circulating PCSK9 as a sex-stratified predictor in primary prevention of cardiovascular disease: Insights from a prospective cohort study in Chinese adults

  ND2023B06, 6 Aug 2026

Sources: api.crossref.org